Central Alerting System
News

25/05/2022: We have updated the alert deadline on NatPSA/2022/002/MHRA to 12/07/2022.


Extended deadlines: given the current situation the below alert deadlines have been extended:This afternoon we have issued a new alert under reference NatPSA/2022/001/MHRA; this was issued in error. We are arranging to remove this alert from the website, there is no need to record any response. We have updated alert NatPSA/2022/002/MHRA. A further email will be sent to recipients this afternoon - 03/05/2022

EFA 2020/001 - extended to 12 February 2021
EFA/2019/005 - extended to 30 April 2021


Tell us what you think of the new National Patient Safety Alert by sharing your views here: https://engage.improvement.nhs.uk/insight/national-patient-safety-credentialing-committee-su

CAS Liaison Officers - we understand that some of you use an email auto forward to share all alerts you receive with colleagues. Each alert suggests who it will be relevant to, some require senior leadership oversight to be identified at the outset and some alerts are sensitive and not suitable for dissemination before your organisation has agreed how to implement the actions. It is difficult to address these requirements if there is an auto-forward before you check the alerts you receive. If you do have an auto-forward in place, then please review it with these points in mind.

 

Attention all providers: Providers should not use the same or similar look and design as National Patient Safety Alerts to disseminate local alerts in their organisation. Examples of providers doing this have been brought to our attention. There is a risk that these alerts become confused with national alerts which meet stringent criteria to ensure the actions are safe without any unforeseen consequences. This practice also risks other organisations picking them up and confusing them for National Patient Safety Alerts, which have a set governance process for providers to follow.



Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency